Paper Details
- Home
- Paper Details
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis.
Author: BianchiRoberta, GrohmannUrsula, MacchiaruloAntonio, OrabonaCiriana, PuccettiPaolo, VolpiClaudia
Original Abstract of the Article :
<b>Introduction</b>: Fingolimod, the first oral disease-modifying treatment (DMT) in multiple sclerosis (MS), is a sphingosine 1-phosphate receptor (S1PR) ligand. Approved in 2010, fingolimod has been extensively studied and has been credited with several mechanisms of actions that contribute to it...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/17460441.2019.1646244
データ提供:米国国立医学図書館(NLM)
Multiple Sclerosis: A Shifting Desert of Symptoms
Multiple sclerosis (MS), a chronic autoimmune disease, is like a vast and shifting desert landscape, where symptoms can emerge and change unpredictably. This research explores the discovery and development of fingolimod, an oral disease-modifying treatment (DMT) for MS. The researchers provide a comprehensive overview of fingolimod's mechanism of action, its efficacy in managing MS symptoms, and its long-term safety and tolerability. Their findings highlight the importance of fingolimod as a valuable treatment option for MS patients and emphasize the need for ongoing research to develop even more effective treatments. This research is like a journey across a desert, seeking to understand the complexities of MS and its potential treatments.
A Beacon of Hope: Fingolimod's Promise
This research underscores the importance of fingolimod as a paradigm shift in MS treatment. By targeting the sphingosine 1-phosphate receptor (S1PR), fingolimod effectively regulates lymphocyte circulation, reducing inflammation and slowing disease progression. This is like discovering a hidden oasis in the desert, offering a source of respite from the relentless symptoms of MS.
Navigating the Dunes of MS: A Continued Journey
This research highlights the importance of ongoing research and development in the field of MS treatment. While fingolimod has been a significant breakthrough, the quest for more effective and targeted therapies continues, with new generations of S1PR ligands being developed to further refine treatment options. This research is like a caravan journey across a vast desert, where the search for new and better treatments continues.
Dr. Camel's Conclusion
This research offers a comprehensive overview of fingolimod, a significant breakthrough in MS treatment. While fingolimod has revolutionized the management of MS, the quest for more effective therapies continues, emphasizing the importance of ongoing research and development in this field. This research is like a compass, guiding us towards a brighter future for those living with MS.
Date :
- Date Completed 2020-03-05
- Date Revised 2020-03-05
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.